Renal upregulation of NCC counteracts empagliflozin-mediated NHE3 inhibition in normotensive but not in hypertensive male rat
American Journal of Physiology-Cell Physiology · 2024
DOI: 10.1152/ajpcell.00351.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2024. Verfasst von Paulo C Castro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Genética e Cardiologia Molecular, Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, São Paulo, Brazil. Hauptthemen laut MEDLINE: Sodium-Hydrogen Exchanger 3, Hypertension, Glucosides, Rats, Inbred SHR. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Abstract (Originalsprache)
This study suggests that reduced NHE3-mediated sodium reabsorption in the renal proximal tubule may account, at least in part, for the BP-lowering effect of SGLT2 inhibitors in the setting of hypertension. It also demonstrates that chronic treatment with SGLT2 inhibitors upregulates NCC activity, phosphorylation, and expression in the distal tubule of normotensive but not hypertensive rats. SGLT2 inhibitor-mediated upregulation of NCC seems crucial to counteract proximal tubule natriuresis in subjects with normal BP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Genética e Cardiologia Molecular, Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, São Paulo, Brazil.
- Instituto Superior de Ciências Biomédicas, Universidade Estadual do Ceará, Fortaleza, Brazil.
- Hospital Universitário Cassiano Antonio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES), Vitória, Brazil.
- Division of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, Oregon, United States.
ORCID-Profile: Paulo C Castro, Flavia L Martins, James A McCormick, Adriana C C Girardi
Förderung
- NIDDK NIH HHS
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Castro, P. C., Santos-Rios, T. M., Martins, F. L., Crajoinas, R. O., Caetano, M. V., Lessa, L. M. A., Luchi, W. M., McCormick, J. A., & Girardi, A. C. C. (2024). Renal upregulation of NCC counteracts empagliflozin-mediated NHE3 inhibition in normotensive but not in hypertensive male rat. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00351.2023
Vancouver
Castro PC, Santos-Rios TM, Martins FL, Crajoinas RO, Caetano MV, Lessa LMA, et al. Renal upregulation of NCC counteracts empagliflozin-mediated NHE3 inhibition in normotensive but not in hypertensive male rat. American Journal of Physiology-Cell Physiology. 2024. doi:10.1152/ajpcell.00351.2023
BibTeX
@article{Castro2024,
author = {Castro, Paulo C and Santos-Rios, Thiago M and Martins, Flavia L and Crajoinas, Renato O and Caetano, Marcos V and Lessa, Lucília M A and Luchi, Weverton M and McCormick, James A and Girardi, Adriana C C},
title = {Renal upregulation of NCC counteracts empagliflozin-mediated NHE3 inhibition in normotensive but not in hypertensive male rat},
journal = {American Journal of Physiology-Cell Physiology},
year = {2024},
doi = {10.1152/ajpcell.00351.2023}
}
EUVIMED